Real-World Data/Late Phase Summit

Real-World Data/Late Phase Summit
November 5-6 | Philadelphia, PA
www.cbinet.com/RWD

Real-World Data/Late Phase Summit – A forum for navigating the latest updates and challenges with real-world data utilization, reimbursement, product value, market access late phase study design and much more – is being held November 5-6 in Philadelphia. Join CBI to convene with peers and discover practical business strategies for real-world data utilization to advance late stage research.

The program features five case studies, an extended payer Q&A, and a diverse group of 18+ industry experts representing Aetna, Astellas, AstraZeneca, Biogen Idec, Bristol Myers Squibb, Johnson & Johnson, Medivation, NICE, Quintiles, Sanofi U.S. and more, will discuss tried and true solutions to the most significant challenges affecting industry today:

• Evaluate the role of medical affairs, clinical development and HEOR in the post-approval process and examine how and when phase 4 studies should be conducted
• Review the current climate of converging payer and regulator real-world evidence needs and some associated key challenges
• Examine what acceptable standards are for real-world data through examining what is required from a payer point-of-view
• Develop better treatment pathways and optimize patient outcomes in comparative effectiveness research
• And much, much more!

As a valued reader of Drug Channels, CBI is offering an exclusive $300 discount when you register by Friday, October 3. (Be sure to mention promo code DCN275).

*Offer valid through October 3, 2014, applies to standard rates only and may not be combined with other offers, category rates, promotions or applied to a current registration.